Trial Profile

Follow-up study to evaluate sustained clearance rates of actinic keratoses up to one year after completion of studies GW01-0702, GW01-0703, GW01-0704, and GW01-0705.

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 28 Apr 2012

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Imiquimod (Primary)
Indications Actinic keratosis
Focus Therapeutic Use
Sponsors Graceway Pharmaceuticals

Most Recent Events

29 Jan 2010 Actual end date (Jul 2009) added as reported by ClinicalTrials.gov.
29 Jan 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
21 May 2008 New trial record.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com